GLI GLI Quality Tool
GLI Quality Tool — Version 2.0

How to monitor and improve TB lab reporting timeliness to clinicians

Timely tuberculosis laboratory reporting helps clinicians begin, adjust, or stop treatment with better information. Delays can affect patient outcomes, increase the chance of transmission, and make it harder for clinical teams to coordinate contact investigation and follow-up. A reliable reporting process therefore belongs within the laboratory’s quality management system, rather than being treated as an informal administrative task.

The most useful approach combines clear turnaround-time targets, dependable communication channels, accurate timestamps, and regular review of results. Laboratories need to understand where time is lost, whether delays affect certain test types or facilities, and whether clinicians receive results in a form they can act on.

The GLI Quality Tool offers a practical framework for this work through its phased roadmap and Quality Systems Essentials. Its focus on documentation, personnel, equipment, assessment, and continual improvement can help a TB laboratory turn reporting performance into a measurable quality objective.

Define what timely reporting means

A laboratory should define timeliness according to the test and the clinical decision it supports. The relevant interval might run from specimen collection to result release, specimen receipt to verified result, or test completion to clinician notification. These are different measures, and combining them can conceal problems in transport, testing, result review, or communication.

For example, a rapid molecular test may require a same-day reporting target, while a culture-based result may follow a longer schedule with interim notifications. The laboratory should document the expected turnaround time for each major service, including sputum microscopy, molecular testing, culture, drug susceptibility testing, and referral tests. Targets should reflect national guidance, clinical needs, operating hours, and local transport realities.

A written definition should also specify when the clock starts and stops. “Result available” may mean entered into the laboratory information system, verified by an authorized person, sent to the requesting facility, or confirmed as received by a clinician. Selecting one consistent definition makes performance data meaningful.

Map the reporting pathway

Reporting delays are often caused by handoffs rather than by the analytical process itself. A specimen may move from a collection site to a district laboratory, then to a referral facility, while the result travels back through a different route. Mapping every step can reveal duplicated data entry, unclear responsibilities, missing contact details, or periods when results wait for manual approval.

Create a simple workflow showing specimen receipt, testing, result verification, dispatch, receipt by the clinical team, and escalation of urgent findings. Record who performs each activity, which communication channel is used, and what happens when the normal route fails. The process should distinguish routine negative results from clinically urgent findings such as rifampicin resistance or a result requiring immediate treatment review.

Staff should have access to consistent operating procedures and role descriptions. The user instructions for the GLI Quality Tool can support a structured review of current practices, helping teams connect reporting problems with broader quality management activities rather than addressing each delay in isolation.

Select indicators that show where time is lost

A useful monitoring system should use a small set of indicators that staff can collect consistently. The median turnaround time shows the typical experience, while the percentage meeting the target shows reliability. The longest delays can still be important, so laboratories may also review the 90th percentile or the proportion of results exceeding a defined escalation threshold.

Break results down by test type, facility, day of the week, transport route, and reporting method. A single overall average may look acceptable even when rural sites, referral tests, or drug resistance results are consistently late. Monthly trend reviews can show whether a process change has produced sustained improvement.

Indicator What it shows Useful breakdown
Median turnaround time Typical time from defined start to result release Test type and facility
Percentage within target Reliability against the agreed standard Month, site, and priority category
Time awaiting verification Delay after testing is complete Shift, reviewer, and test platform
Time from release to clinician receipt Effectiveness of result communication Communication channel and facility
Number of overdue results Current workload and unresolved delays Age of result and responsible unit
Documented urgent-result notifications Safety of escalation for critical findings Result category and notification method

Data quality is as important as the indicator itself. Each record should include dependable timestamps, the requesting facility, test category, and notification status. If staff enter times retrospectively, the laboratory should mark that limitation and avoid presenting the data as more precise than it is.

Strengthen people and daily workflow

Timeliness depends on staffing arrangements that match workload. Laboratories should examine whether testing, verification, and reporting responsibilities are covered during evenings, weekends, public holidays, and staff absences. A result that is ready but waits until the next working day may represent a scheduling problem rather than a technical delay.

Cross-training can reduce dependence on one person who knows how to verify results or contact a particular clinic. Competency records should show that authorized staff can perform the tasks safely and correctly. Supervisors can use workload data to adjust shifts, prioritize urgent tests, and plan leave coverage without weakening quality controls.

Communication details must be current. Each submitting facility should have named contacts, backup contacts, preferred channels, and a documented escalation route. When an urgent result is communicated by telephone or secure message, the staff member should record the date, time, recipient, result category, and any read-back or acknowledgement required by procedure.

Use electronic systems without losing control

Electronic reporting can reduce transcription, speed up delivery, and make overdue results easier to identify. It does not automatically solve poor processes. If patient identifiers are inconsistent, interfaces fail, or staff bypass verification, a digital system may create faster errors.

Laboratories moving from paper registers to electronic records should define data fields, user permissions, validation rules, backup procedures, and downtime arrangements. The guide to electronic TB records provides relevant practical direction for managing this transition while maintaining continuity and data integrity.

Automation should support, rather than replace, professional review. The system can flag results outside expected ranges, identify tests approaching their reporting deadline, and generate facility-specific worklists. Authorized personnel must still confirm that the result belongs to the correct patient, meets quality criteria, and is suitable for release.

Security and confidentiality also matter. Access should be limited by role, audit trails should be retained, and printed or downloaded reports should be controlled. When electronic reporting is unavailable, staff need a tested backup process and a clear method for entering or reconciling delayed records once service is restored.

Turn monitoring into corrective action

Regular review meetings should focus on causes and decisions, not only on ranking staff or facilities. When performance falls below target, the team can use a simple root-cause method such as process mapping, the five whys, or review of a sample of delayed records. The objective is to identify a change that can be tested and measured.

Corrective actions should have an owner, a deadline, and a defined measure of success. For instance, a laboratory might revise the urgent-result escalation procedure, add a second evening verifier, improve courier schedules, or create an automated overdue-result list. The team should review whether the intervention reduced delays without increasing errors or undocumented communications.

Practical priorities for improvement

Performance review should be visible to the people who influence it. A simple dashboard on a staff noticeboard or shared digital workspace can display the percentage of results meeting target, overdue workload, and current corrective actions. Sharing progress helps connect daily work with patient care and makes improvement a team responsibility.

Make timely reporting routine

An effective TB laboratory reporting system is predictable, traceable, and responsive to clinical urgency. It gives staff clear expectations, gives managers evidence for resource decisions, and gives clinicians confidence that important results will arrive through a dependable channel.

Begin with a baseline covering several weeks or months, then choose one or two high-impact bottlenecks to address first. Recheck performance after the change, document what worked, and incorporate successful practices into procedures, training, and internal assessments. This cycle supports continual improvement without requiring a complex measurement system.

Laboratories can use the GLI Quality Tool to organize this work across its quality essentials and implementation phases. Start by defining the reporting process, measure its actual performance, involve the staff and clinical partners who use it, and act on the evidence. A consistent review routine can turn faster reporting from an individual effort into a sustained laboratory standard.